What does sermorelin do, regardless of delivery route?
Sermorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), the 29-amino-acidpeptide the hypothalamus naturally releases in pulses to signal the pituitary to secrete growth hormone (GH). Unlike exogenous GH, sermorelin preserves the pituitary’s own regulatory feedback loop: it stimulates GH release rather than replacing it, and the pituitary’s normal axis safeguards remain intact.
This mechanism is the same regardless of administration route. What changes between sublingual and injection is the pharmacokinetic profile — specifically, how much peptide reaches systemic circulation and how quickly it does so.
How does subcutaneous sermorelin injection work?
Subcutaneous injection delivers sermorelin just under the skin, where it is absorbed into the bloodstream relatively quickly. The subcutaneous route is well-characterized for peptide delivery: it bypasses the gastrointestinal tract entirely and avoids first-pass hepatic metabolism. Peak plasma levels are reached within minutes to a couple of hours depending on the formulation.
Injection is the most studied administration route for sermorelin and the basis for most of the published clinical data on pituitary response and downstream IGF-1 effects. For patients comfortable with subcutaneous self-injection, it represents a predictable pharmacokinetic profile that clinicians can work with using established dosing frameworks.
The practical barrier is straightforward: some patients are averse to needles, find daily injections burdensome, or have logistical constraints that make injections less consistent. Those patients are often the ones asking about sublingual tablets.
Sermorelin’s mechanism is identical either way — only the pharmacokinetics differ, so the route is a fit-and-tolerance decision, not a better-or-worse one.
How do sermorelin sublingual tablets absorb through the oral mucosa?
Sublingual sermorelin is compounded as a tablet or troche that dissolves under the tongue. The oral mucosa — the tissue lining the floor of the mouth — is highly vascular, and drugs absorbed there enter circulation without passing through the gastrointestinal tract or the hepatic portal system. This is meaningfully different from swallowing a capsule, where peptides are typically degraded by gastric acid and proteolytic enzymes before they can reach systemic circulation.
The sublingual route offers genuine advantages for peptide delivery compared to oral ingestion, but it typically achieves lower bioavailability than subcutaneous injection. The oral mucosa is less permeable than subcutaneous tissue, and the amount of peptide that actually reaches systemic circulation is generally lower for an equivalent nominal dose. Licensed 503A pharmacies formulate sublingual sermorelin with absorption enhancers and at higher nominal doses to account for this, but the pharmacokinetic profile differs from injection.
Published pharmacokinetic data specifically on sublingual sermorelin is more limited than the injection literature. Clinicians working with this route rely on the broader sublingual peptide and small-molecule literature, patient response, and relevant labs (IGF-1 monitoring) to calibrate dosing over time.
Practical comparison
| Factor | Subcutaneous Injection | Sublingual Tablet |
|---|---|---|
| Bioavailability | Higher; directly absorbed subcutaneously | Lower; absorbed through oral mucosa |
| Administration | Daily injection, typically at bedtime | Dissolve under tongue, typically at bedtime |
| Needle required | Yes | No |
| Published data | Extensive for subcutaneous route | More limited; route-specific data sparse |
| Storage | Refrigerated vial; reconstitution required | Room temperature typically; check pharmacy instructions |
Which sermorelin route is right for you: injection or sublingual?
Neither route is inherently superior for every patient. A clinician will consider factors including your baseline IGF-1 and GH-related labs, your tolerance for injection, consistency of administration, your specific goals, and your overall health picture when recommending a route. Some patients start with one route and transition to the other based on response and convenience.
What matters more than the delivery mechanism is the consistency of administration and the alignment between your dosing protocol and your monitoring plan. Sermorelin works by supporting pulsatile GHRH signaling — that pulsatility is best preserved by consistent daily administration near sleep onset, when the pituitary’s natural GH pulse is strongest.
A note on compounding quality
Regardless of route, sermorelin is a compounded medication prepared by licensed 503A pharmacies in the USA — not an FDA-approved finished drug. Compounded sermorelin is not the same as a manufactured pharmaceutical product and has not undergone the same FDA approval process. When evaluating a sermorelin protocol, the sourcing standard matters: PepScribe works with US-licensed 503A compounding pharmacies that operate under USP standards. No hidden overseas supply chain. No unregulated research chemical vendors.
Frequently asked questions
Are sermorelin sublingual tablets effective?
Sublingual sermorelin is available through some compounding pharmacies and may offer a needle-free alternative for patients who are not candidates for injection. Bioavailability via the sublingual route is generally lower than subcutaneous injection; a clinician can review whether sublingual dosing is appropriate for your goals.
What is the difference between sermorelin injection and sublingual?
Sermorelin injection delivers the peptide subcutaneously (under the skin), where it is absorbed directly into circulation. Sublingual sermorelin dissolves under the tongue and absorbs through the oral mucosa, bypassing first-pass hepatic metabolism but typically achieving lower peak serum levels than injection at equivalent doses.
Can I get sermorelin without injections?
Yes, sublingual tablet formulations of sermorelin are available through licensed US 503A compounding pharmacies with a clinician prescription. Whether sublingual is the right route for you depends on your specific goals and health history, which a clinician will evaluate.
Is sermorelin a compounded medication?
Sermorelin is a Tier 1 peptide available from licensed 503A compounding pharmacies in the USA. Compounded sermorelin is not an FDA-approved drug; it is prepared individually for each patient by a licensed US pharmacy.
How often is sermorelin taken sublingually vs. by injection?
Sermorelin is typically administered daily regardless of route, as it mimics the natural pulsatile pattern of growth hormone-releasing hormone (GHRH). Frequency and dose are set by the prescribing clinician based on the patient's goals and labs.